AU Patent

AU2022291752A1 — Synthetic preparation for diroximel fumarate

Assigned to Biogen MA Inc · Expires 2024-01-04 · 2y expired

What this patent protects

Disclosed is a method of preparing diroximel fumarate represented by the following structural formula (I) The method comprises reacting ethylene carbonate with succinimide to form a hydroxyethyl succinimide intermediate; and reacting the intermediate with monomethyl fumarate to f…

USPTO Abstract

Disclosed is a method of preparing diroximel fumarate represented by the following structural formula (I) The method comprises reacting ethylene carbonate with succinimide to form a hydroxyethyl succinimide intermediate; and reacting the intermediate with monomethyl fumarate to form the product compound.

Drugs covered by this patent

Patent Metadata

Patent number
AU2022291752A1
Jurisdiction
AU
Classification
—
Expires
2024-01-04
Drug substance claim
No
Drug product claim
No
Assignee
Biogen MA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.